Your browser doesn't support javascript.
loading
Which patients with metastatic hormone-sensitive prostate cancer benefit from docetaxel: a systematic review and meta-analysis of individual participant data from randomised trials.
Vale, Claire L; Fisher, David J; Godolphin, Peter J; Rydzewska, Larysa H; Boher, Jean-Marie; Burdett, Sarah; Chen, Yu-Hui; Clarke, Noel W; Fizazi, Karim; Gravis, Gwenaelle; James, Nicholas D; Liu, Glenn; Matheson, David; Murphy, Laura; Oldroyd, Robert E; Parmar, Mahesh K B; Rogozinska, Ewelina; Sfumato, Patrick; Sweeney, Christopher J; Sydes, Matthew R; Tombal, Bertrand; White, Ian R; Tierney, Jayne F.
Afiliação
  • Vale CL; MRC Clinical Trials Unit at UCL, Institute of Clinical Trials and Methodology, London, UK. Electronic address: claire.vale@ucl.ac.uk.
  • Fisher DJ; MRC Clinical Trials Unit at UCL, Institute of Clinical Trials and Methodology, London, UK.
  • Godolphin PJ; MRC Clinical Trials Unit at UCL, Institute of Clinical Trials and Methodology, London, UK.
  • Rydzewska LH; MRC Clinical Trials Unit at UCL, Institute of Clinical Trials and Methodology, London, UK.
  • Boher JM; Biostatistics Unit, Institut Paoli-Calmettes, Marseille, France.
  • Burdett S; MRC Clinical Trials Unit at UCL, Institute of Clinical Trials and Methodology, London, UK.
  • Chen YH; Department of Biostatistics and Computational Biology ECOG-ACRIN Cancer Research Group, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Clarke NW; Department of Surgery and Department of Urology, The Christie and Salford Royal Hospitals, Manchester, UK.
  • Fizazi K; Department of Cancer Medicine, Institut Gustave Roussy, Paris, France.
  • Gravis G; Department of Medical Oncology, Institut Paoli-Calmettes, Marseille, France.
  • James ND; Institute of Cancer Research, London, UK.
  • Liu G; Department of Urology, Department of Medicine, University of Wisconsin Carbone Cancer Center, University of Wisconsin School of Medicine and Public Health, Madison, WI, USA.
  • Matheson D; MRC Clinical Trials Unit at UCL, Institute of Clinical Trials and Methodology, London, UK.
  • Murphy L; MRC Clinical Trials Unit at UCL, Institute of Clinical Trials and Methodology, London, UK.
  • Oldroyd RE; MRC Clinical Trials Unit at UCL, Institute of Clinical Trials and Methodology, London, UK.
  • Parmar MKB; MRC Clinical Trials Unit at UCL, Institute of Clinical Trials and Methodology, London, UK.
  • Rogozinska E; MRC Clinical Trials Unit at UCL, Institute of Clinical Trials and Methodology, London, UK.
  • Sfumato P; Biostatistics Unit, Institut Paoli-Calmettes, Marseille, France.
  • Sweeney CJ; SAiGENCI, University of Adelaide, Adelaide, SA, Australia.
  • Sydes MR; MRC Clinical Trials Unit at UCL, Institute of Clinical Trials and Methodology, London, UK.
  • Tombal B; Institut de Recherche Clinique, Université Catholique de Louvain, Louvain-la-Neuve, Belgium.
  • White IR; MRC Clinical Trials Unit at UCL, Institute of Clinical Trials and Methodology, London, UK.
  • Tierney JF; MRC Clinical Trials Unit at UCL, Institute of Clinical Trials and Methodology, London, UK.
Lancet Oncol ; 24(7): 783-797, 2023 07.
Article em En | MEDLINE | ID: mdl-37414011
Assuntos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Neoplasias da Próstata Tipo de estudo: Clinical_trials / Diagnostic_studies / Prognostic_studies / Systematic_reviews Limite: Humans / Male Idioma: En Revista: Lancet Oncol Assunto da revista: NEOPLASIAS Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Neoplasias da Próstata Tipo de estudo: Clinical_trials / Diagnostic_studies / Prognostic_studies / Systematic_reviews Limite: Humans / Male Idioma: En Revista: Lancet Oncol Assunto da revista: NEOPLASIAS Ano de publicação: 2023 Tipo de documento: Article